Interaction of NF-κB and Wnt/β-catenin Signaling Pathways in Alzheimer’s Disease and Potential Active Drug Treatments

被引:1
|
作者
Xiao Liu
Kaiyue Wang
Xing Wei
Tian Xie
Bin Lv
Qian Zhou
Xiaoying Wang
机构
[1] Tianjin University of Traditional Chinese Medicine,State Key Laboratory of Modern Chinese Medicine
[2] Tianjin University of Traditional Chinese Medicine,College of Traditional Chinese Medicine
[3] University of Occupational and Environmental Health,Department of Anatomy, School of Medicine
来源
Neurochemical Research | 2021年 / 46卷
关键词
Alzheimer’s disease; Neuroinflammation; Synaptic dysfunction; NF-κb; Wnt/β-catenin; Natural compounds;
D O I
暂无
中图分类号
学科分类号
摘要
The most important neuropathological features of Alzheimer's disease (AD) are extracellular amyloid-β protein (Aβ) deposition, tau protein hyperphosphorylation and activation of neurometabolic reaction in the brain accompanied by neuronal and synaptic damage, and impaired learning and memory function. According to the amyloid cascade hypothesis, increased Aβ deposits in the brain to form the core of the senile plaques that initiate cascade reactions, affecting the synapses and stimulating activation of microglia, resulting in neuroinflammation. A growing number of studies has shown that NF-κB and Wnt/β-catenin pathways play important roles in neurodegenerative diseases, especially AD. In this review, we briefly introduce the connection between neuroinflammation-mediated synaptic dysfunction in AD and elaborated on the mechanism of these two signaling pathways in AD-related pathological changes, as well as their interaction. Based on our interest in natural compounds, we also briefly introduce and conduct preliminary screening of potential therapeutics for AD.
引用
收藏
页码:711 / 731
页数:20
相关论文
共 50 条
  • [1] Interaction of NF-κB and Wnt/β-catenin Signaling Pathways in Alzheimer's Disease and Potential Active Drug Treatments
    Liu Xiao
    Wang Kaiyue
    Wei Xing
    Xei Tian
    Lv Bin
    Zhou Qian
    Wang Xiaoying
    NEUROCHEMICAL RESEARCH, 2021, 46 (04) : 711 - 731
  • [2] Wnt/β-Catenin Signaling in Alzheimer's Disease
    De Ferrari, Giancarlo V.
    Avila, Miguel E.
    Medina, Matias A.
    Perez-Palma, Eduardo
    Bustos, Bernabe I.
    Alarcon, Marcelo A.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2014, 13 (05) : 745 - 754
  • [3] OTULIN Can Improve Spinal Cord Injury by the NF-κB and Wnt/β-Catenin Signaling Pathways
    Wang, Qianhui
    Wang, Lvxia
    Botchway, Benson O. A.
    Zhang, Yong
    Huang, Min
    Liu, Xuehong
    MOLECULAR NEUROBIOLOGY, 2024, 61 (11) : 8820 - 8830
  • [4] Dexamethasone ameliorates Alzheimer's pathological condition via inhibiting Nf-κB and mTOR signaling pathways
    Haghighatseir, Niloofar
    Ashrafi, Hajar
    Rafiei, Pedram
    Azadi, Amir
    BIOINTERFACE RESEARCH IN APPLIED CHEMISTRY, 2020, 10 (04): : 5792 - 5796
  • [5] Forsythoside B attenuates memory impairment and neuroinflammation via inhibition on NF-κB signaling in Alzheimer's disease
    Kong, Fan'ge
    Jiang, Xue
    Wang, Ruochen
    Zhai, Siyu
    Zhang, Yizhi
    Wang, Di
    JOURNAL OF NEUROINFLAMMATION, 2020, 17 (01)
  • [6] Forsythoside B attenuates memory impairment and neuroinflammation via inhibition on NF-κB signaling in Alzheimer’s disease
    Fan’ge Kong
    Xue Jiang
    Ruochen Wang
    Siyu Zhai
    Yizhi Zhang
    Di Wang
    Journal of Neuroinflammation, 17
  • [7] Anti-Neuroinflammatory Potential of Polyphenols by Inhibiting NF-κB to Halt Alzheimer's Disease
    Uddin, Md Sahab
    Hasana, Sharifa
    Ahmad, Jamil
    Hossain, Md Farhad
    Rahman, Md Mosiqur
    Behl, Tapan
    Rauf, Abdur
    Ahmad, Ausaf
    Hafeez, Abdul
    Perveen, Asma
    Ashraf, Ghulam Md
    CURRENT PHARMACEUTICAL DESIGN, 2021, 27 (03) : 402 - 414
  • [8] Inflammation and NF-κB in Alzheimer's Disease and Diabetes
    Granic, Ivica
    Dolga, Amalia M.
    Nijholt, Ingrid M.
    van Dijk, Gertjan
    Eisel, Ulrich L. M.
    JOURNAL OF ALZHEIMERS DISEASE, 2009, 16 (04) : 809 - 821
  • [9] The Role of APOE and NF-κB in Alzheimer's Disease
    Davies, Don A.
    IMMUNO, 2021, 1 (04): : 391 - 399
  • [10] NF-κB as a Key Mediator of Brain Inflammation in Alzheimer's Disease
    Hwang, Chul Ju
    Choi, Dong-Young
    Park, Mi Hee
    Hong, Jin Tae
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2019, 18 (01) : 3 - 10